Findings

What do systematic reviews say?

3,747 questions · 3,943 findings · 594 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 784 · 19.9%GRADE not reported 530 · 13.4%Very low 1,040 · 26.4%Low 981 · 24.9%Moderate 444 · 11.3%High 164 · 4.2%

Intervention not reported

Utilisation of research (Thailand) (for six obstetric practices: social support during labour, magnesium sulphate for eclampsia, corticosteroids to women with preterm birth, selective episiotomy, antibiotic use at caesarean section and vacuum extr... · Healthcare decision makers, health system managers or policy makers

1 finding from 1 review

Interventions to improve the use of systematic reviews in decision‐making by health system managers, policy makers and… 2012 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Moderate

Intervention not reported

Utilisation of research (Mexico) (for six obstetric practices: social support during labour, magnesium sulphate for eclampsia, corticosteroids to women with preterm birth, selective episiotomy, antibiotic use at caesarean section and vacuum extrac... · Healthcare decision makers, health system managers or policy makers

1 finding from 1 review

Interventions to improve the use of systematic reviews in decision‐making by health system managers, policy makers and… 2012 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Moderate

Intervention not reported

Utilisation of research (4 obstetric practices: use of polyglycolic acid sutures, ventouse for instrumental delivery, prophylactic antibiotics in caesarean section, and prophylactic corticosteroids in preterm deliveries).2 · Healthcare decision makers, health system managers or policy makers

1 finding from 1 review

Interventions to improve the use of systematic reviews in decision‐making by health system managers, policy makers and… 2012 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Low

Vaccination vs placebo

Persistence of PHN among all subjects a numerical rating scale for pain1 · people at risk for postherpetic neuralgia

Vaccination leads to lower persistence of PHN among all subjects a numerical rating scale for… compared with placebo (high certainty).

1 finding from 1 review

Vaccination for preventing postherpetic neuralgia 2011 · Cochrane Headline outcomes only
RR 0.31 [0.18, 0.54]
1 study · 38501 participants
High

Vaccination vs placebo

Persistence of PHN among subjects developing herpes zoster a numerical rating scale for pain1 · people at risk for postherpetic neuralgia

Vaccination showed no clear difference in persistence of PHN among subjects developing herpes zoster a… compared with placebo (moderate certainty).

1 finding from 1 review

Vaccination for preventing postherpetic neuralgia 2011 · Cochrane Headline outcomes only
RR 0.64 [0.38, 1.09]
1 study · 957 participants
Moderate

Corticosteroids vs placebo

Caloric extent of recovery (improvement as a % in lateralisation of electronystagmography on caloric testing) · Patients with idiopathic acute vestibular dysfunction (vestibular neuritis)

2 findings from 1 review

Corticosteroids for the treatment of idiopathic acute vestibular dysfunction (vestibular neuritis) 2011 · Cochrane Headline outcomes only
no estimate extracted
1 study · 30 participants
Low
Corticosteroids for the treatment of idiopathic acute vestibular dysfunction (vestibular neuritis) 2011 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 89 participants
Low

Corticosteroids vs placebo

Complete caloric recovery · Patients with idiopathic acute vestibular dysfunction (vestibular neuritis)

Corticosteroids may leads to higher complete caloric recovery compared with placebo (low certainty).

2 findings from 1 review

Corticosteroids for the treatment of idiopathic acute vestibular dysfunction (vestibular neuritis) 2011 · Cochrane Headline outcomes only
RR 2.81 [1.32, 6]
2 studies · 50 participants
Low
Corticosteroids for the treatment of idiopathic acute vestibular dysfunction (vestibular neuritis) 2011 · Cochrane Headline outcomes only
RR 1.58 [0.45, 5.62]
2 studies · 89 participants
Low

Topical methyl salicylate (Theraflex-TMJ) vs placebo

Spontaneous masseter muscle pain (numerical graph rating scale) · Adult patients aged >=18 years, clinically or radiographically diagnosed with TMD (McNeill 1997 criteria); moderate to severe pain of…

Topical methyl salicylate (Theraflex-TMJ) led to lower spontaneous masseter muscle pain (numerical graph rating scale) compared with placebo; GRADE not reported.

1 finding from 1 review

Pharmacological interventions for pain in patients with temporomandibular disorders 2010 · Cochrane All outcomes
15 days
MD -2.00 [-2.38, -1.62]
1 study · 52 participants
GRADE not reported

Topical methyl salicylate (Theraflex-TMJ) vs placebo

Spontaneous pain in the TMJ (VAS) · Adult patients aged >=18 years, clinically or radiographically diagnosed with TMD (McNeill 1997 criteria); moderate to severe pain of…

Topical methyl salicylate (Theraflex-TMJ) led to lower spontaneous TMJ pain (numerical graph rating scale) compared with placebo; GRADE not reported.

1 finding from 1 review

Pharmacological interventions for pain in patients with temporomandibular disorders 2010 · Cochrane All outcomes
15 days
MD -0.90 [-1.35, -0.45]
1 study · 52 participants
GRADE not reported

Intervention not reported

Functional status (generic) Sickness Impact Profile (0‐136) short‐term · adults with chronic low‐back pain

1 finding from 1 review

Behavioural treatment for chronic low‐back pain 2010 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 61 participants
Low

Intervention not reported

Functional status (generic) Sickness Impact Profile (0‐136) intermediate‐term · adults with chronic low‐back pain

1 finding from 1 review

Behavioural treatment for chronic low‐back pain 2010 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 47 participants
Very low

Intervention not reported

Functional status (generic) Sickness Impact Profile (0‐136) long‐term · adults with chronic low‐back pain

1 finding from 1 review

Behavioural treatment for chronic low‐back pain 2010 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 51 participants
Very low

Intervention not reported

Functional status (generic) various scales short‐term · adults with chronic low‐back pain

1 finding from 1 review

Behavioural treatment for chronic low‐back pain 2010 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 77 participants
Low

Intervention not reported

Functional status (generic) various scales intermediate‐term · adults with chronic low‐back pain

1 finding from 1 review

Behavioural treatment for chronic low‐back pain 2010 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 61 participants
Low

Intervention not reported

Functional status (generic) various scales long‐term · adults with chronic low‐back pain

1 finding from 1 review

Behavioural treatment for chronic low‐back pain 2010 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 66 participants
Low

Summary of findings: Behavioural treatments vs waiting list control

Functional status (generic) various scales short‐term · adults with chronic low‐back pain

1 finding from 1 review

Behavioural treatment for chronic low‐back pain 2010 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 74 participants
Low

Summary of findings: Behavioural treatments + other treatments vs other treatments alone

Functional ability · adults with chronic low‐back pain

2 findings from 1 review

Behavioural treatment for chronic low‐back pain 2010 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 59 participants
Low
Behavioural treatment for chronic low‐back pain 2010 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 51 participants
Low

Summary of findings: Behavioural treatments vs waiting list control

Functional ability · adults with chronic low‐back pain

1 finding from 1 review

Behavioural treatment for chronic low‐back pain 2010 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 87 participants
Low

Intervention not reported

asteric* denotes studies reporting both speed and crash outcomes.

The review found no eligible studies for this question.

1 finding from 1 review

Speed cameras for the prevention of road traffic injuries and deaths 2010 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

ZOTEPINE vs CLOZAPINE

Mental state: psychopathology Total endpoint data, BPRS (higher score = worse, scale from: 0‐126) · patients with schizophrenia

1 finding from 1 review

Zotepine versus other atypical antipsychotics for schizophrenia 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 59 participants
Very low